The Nightly: Banging Heads

New Post Public Reply Private Reply Replies (0) Message Board
Lmcat
The Nightly: Banging Heads Against The Wall

July 16, 2013 : We've received a few emails tonight, marveling at our dead-on analysis in this morning's pre-market Daily Trades Report, in which we prognosticated poor results in today's Pumping and Dumping of XUII  ETEK and FITX .  According to tonight's edition of  The Nightly , we were dead-on.

XUII couldn't get by the psychological wall established when shares hit an all-time high back in May.  The many crashes and rebuilds of the share price seems to have buyers skittish about establishing a new high. Those experienced with past APS frauds know that the share price can crash again on a moments notice, adding to the anxiety. Also possible, APS could be looking to control the share price and keep it from getting away in order to maintain the interest of whatever newbies are still falling into the trap.  We'd expect further attempts to break the wall over the coming day or so, before APS and its partners-in-crime capitulate and once again take whatever they can get for shares.  While APS claims that they will stick with this pick throughout the summer, we cannot see this going much longer than another two to four weeks, as XUII will have to post financials and then the viability of the share price will definitely come into question.

Greed killed for those volunteering to hold the  ETEK bag today. As expected, the at least 50 touts that pimped these shares today created increased buying volume which insiders were happy to accommodate by providing an ample supply of stock.  We expect the sell-off to pick up speed  tomorrow , especially if additional touts are not on board to continue the facade.

FITX behaved in the way expected whenever that stock is pimped. As per usual, losing buys far outweighed those that closed in the green. This morning we made a point of the 430,444,420 shares created during the last quarter that would be looking for new homes in the coming days. With rampant dilution bringing the issued and outstanding to over 1.76 billion shares, we wouldn't be surprised to see a reverse split coming in the not too distant future.

AXXE was another issue in which almost every buy finished in the red today.   More than half of all buys in  ARTH and SWET closed down on the day.

We're watching for an inevitable rush to the exits in the next day or two on today's perfect performers,  AMPG and  CLNO , in which every buy took place at or below the close.   Same goes for good performers CFGI and NAMG , as well as BFLX  which has a fabled history of separating investors from their wallets.

We continue to present PumpsandDumps.com as a free public service.  We do not short stocks.  Never have.  Never will.  Anybody who says otherwise is just a liar.  Period.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cloud Software Group's $2B Debt Offer Wraps Up

Updated Category News Views 25

Sizing Up Cloud Software Group’s Recent Maneuver Whoever thought navigating debt was a dull spectacle hasn’t kept up with Cloud Software Group's recent financial theatrics. With a $2 billion cap on the table, their cash tender offer for 9.00% Senior Secured Second Lien Notes due 2029 didn’t just happen; it paraded onto the financial stage and left a noteworthy...

Continue Reading
Pak Mail Expands: Franchisee Adds Location Fast

Updated Category News Views 66

Franchise Growth: Adding Another Brick When's the last time you heard of a franchisee eager enough to nab a second location? Well, that's exactly what's happening with Manny Zussman, who’s decided his Boulder Pak Mail outlet wasn’t keeping him busy enough. This entrepreneurial spirit's on full display as he's launching another Pak Mail over in Westminster, Colorado....

Continue Reading
Laboratoires Pierre Fabre and XtalPi Unite for AI-Driven Drug Hunt

Updated Category News Views 213

An Unexpected Turn in the Drug Discovery Arena It's not every day that you see a historic French pharma powerhouse and a cutting-edge Chinese tech firm join forces. On one side, we've got Laboratoires Pierre Fabre, steeped in the history and nitty-gritty of clinical drug development. On the other, we’ve got XtalPi Holdings Limited (2228.HK), bringing their high-tech AI...

Continue Reading
Huawei's 2026 Leap in Gartner Magic Quadrant Recognition

Updated Category News Views 92

China's Telecom Giant Steps Up Globally Gartner's all about benchmarks and bragging rights in the tech world, and brother, Huawei just grabbed a major piece of that spotlight in 2026. They've snagged a spot in the coveted Leaders Quadrant of the Gartner Magic Quadrant for Infrastructure Platform Consumption Services. Now, why should folks with skin in the game care?...

Continue Reading
WSIB Slashes Registration Time with Guidewire Boost

Updated Category News Views 39

Quick Fix: Streamlining Ontario's Employer Registration Alright, let's cut through the formalities and tell it like it is: Ontario's Workplace Safety and Insurance Board (WSIB) isn't messing around anymore. They've yanked their antiquated paper-laden process into the digital age, slicing the employer registration wait down from an agonizing eight to ten-day ordeal to a...

Continue Reading
E Ink Backs Soofa: A Solar-Powered Signage Game Changer

Updated Category News Views 68

Pioneering a New Era in Community Signage If you ever thought those static community bulletin boards were outdated, you're not alone. E Ink, one of the big players in ePaper technology, has decided to shake things up by investing in Soofa. These folks at Soofa know a thing or two about connecting communities with smart solutions. Their solar-powered kiosks might just be...

Continue Reading
Reindeer Expands With Google Cloud Marketplace Launch

Updated Category News Views 81

Reindeer Rides Google Cloud's Tailwinds Alright, folks, here's a new twist in the world of enterprise AI that's got my eyeballs popped. Reindeer, that plucky outfit from New York and Tel Aviv, has cozied up with Google Cloud in a move that's set to turn heads in the sector. Now, you might hear "agentic AI" and think it's just some fancy jargon, but this is where it gets...

Continue Reading
Telespazio & Rivada Forge Secure Satellite Network

Updated Category News Views 131

Rivada's Outernet: A New Era of Connectivity Forget the terrestrial wires; we're talking about 600 satellites playing a space-age game of telephone. That's Rivada's Outernet for you, an orbital mesh network that's about to upend the very nature of global communications. Telespazio's new partnership with Rivada is like strapping a rocket onto secure connectivity in the...

Continue Reading
Energenesis Tackles Space Anemia with ATP Boost

Updated Category News Views 47

Gearing Up for Space Medicine: Enter Energenesis With the cosmic frontier drawing investor eyes and day-to-day operations inching skyward, here comes Energenesis Biomedical (TWSE: 6657), poking its head into space medicine. This isn’t just another biotech firm looking to throw drugs at terrestrial problems. No, Energenesis shot its shot at TASTI 2026 with its...

Continue Reading
Gold.com Faces Fiduciary Investigation by Levi & Korsinsky

Updated Category News Views 10

Gold.com in Hot Water: What Shareholders Need to Know You ever wonder how firms like Gold.com find themselves in sticky situations before the ink's dry on the quarterly report? Well, strap in because Levi & Korsinsky, LLP is poking around to see if some officers and directors over there have taken a stroll down Breach Avenue. And let me tell you, if you're holding onto...

Continue Reading

Top 5 Most Recently Viewed Articles

Potential Legal Scrutiny for aTyr Pharma: Seeking Justice for Investors

Updated Category News Views 298

Overview of aTyr Pharma, Inc. aTyr Pharma, Inc. is a biotechnology firm devoted to advancing innovative therapies for patients with rare diseases. The company focuses on immunological and neurological disorders, working diligently to bring solutions to underserved markets. As the company navigates through the complexities of drug development, it also faces scrutiny...

Continue Reading
Signs of Needing Home Care: Key Insights from Experts

Updated Category News Views 42

Spotting the Subtle Shifts Navigating the path of aging isn't exactly a walk in the park, and families often find themselves squinting to see the subtle signs that an aging parent might need a little more than just occasional check-ins. We’re not talking dramatic meltdowns here—no, it’s about those creeping changes that sneak in like an old song you haven’t heard...

Continue Reading
UPLIZNA® Receives FDA Approval for Generalized Myasthenia Gravis

Updated Category News Views 164

UPLIZNA® Gains FDA Approval for gMG in Adults UPLIZNA is an innovative new treatment for adults battling generalized myasthenia gravis (gMG), a debilitating autoimmune disorder. This approval, granted by the U.S. Food and Drug Administration (FDA), heralds a new era for gMG patients, providing them with deep and durable control over their symptoms. The most appealing...

Continue Reading
Monster Energy Launches Refreshing Strawberry Shot Variant

Updated Category News Views 254

Monster Energy Unveils Strawberry Shot Monster Energy is thrilled to announce the introduction of Monster Energy Strawberry Shot, set to captivate fans with its unique twist on the classic OG flavor. This new version infuses the iconic energy blend with an enticing hint of strawberry, promoting an enjoyable and refreshing experience. A Fresh Take on a Classic Favorite...

Continue Reading
Cohen & Steers Quarterly Performance Insights and Future Outlook

Updated Category News Views 163

Cohen & Steers Quarterly Performance Insights Cohen & Steers, Inc. (NYSE: CNS) announced its financial outcomes for the recent quarter ending on June 30. This report sheds light on the firm’s commitment to delivering exceptional results in the investment management sector. Understanding the Second Quarter Financials The recent financial report reflects the company’s...

Continue Reading